Erythromycin Panpharma

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Składnik aktywny:

Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin;  

Dostępny od:

Multichem NZ Limited

Dawkowanie:

1 g

Forma farmaceutyczna:

Powder for infusion

Skład:

Active: Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin  

Typ recepty:

Prescription

Wskazania:

Upper respiratory tract infections caused by Streptococcus pyogenes (Group A beta haemolytic streptococci); Lower respiratory tract infections caused by Streptococcus pyogenes (Group A betahaemolytic streptococci); Skin and skin structure infections caused by Streptococcus pyogenes.

Podsumowanie produktu:

Package - Contents - Shelf Life: Vial, glass, 20 mL glass vial type III, in a cardboard carton - 1 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 10 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 25 dose units - 3 years from date of manufacture stored at or below 30°C protect from light

Data autoryzacji:

2017-08-14